Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera
- 12 June 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (29), 3821-3830
- https://doi.org/10.1016/j.vaccine.2009.04.008
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only VaccinationJournal of Virology, 2008
- Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of AdministrationJournal of Virology, 2008
- The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methodsVaccine, 2008
- Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteersVaccine, 2008
- Oral cholera vaccines: use in clinical practiceThe Lancet Infectious Diseases, 2006
- Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccineVaccine, 2006
- Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1Journal of Virology, 2005
- Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgRVaccine, 2004
- Cholera VaccinesClinical Infectious Diseases, 2000
- Involvement of B-1 cells in mucosal immunity and autoimmunityImmunology Today, 1995